top of page
Search


FDA Removes Ozempic from Shortage List, Reshaping Market and 503B Landscape
The U.S. Food and Drug Administration (FDA) has officially removed Ozempic (semaglutide) from its Drug Shortage Database as of February...
John Lyder
Feb 282 min read


US Market Faces Ongoing Ozempic Shortage as FDA Steps In
The United States is grappling with a persistent shortage of Ozempic (semaglutide), Novo Nordisk’s blockbuster diabetes and weight-loss...
John Lyder
Dec 3, 20242 min read


Monoclonal antibody therapy for COVID-19
Monoclonal antibody (mAb) therapy, also called monoclonal antibody infusion treatment, is a way of treating COVID-19. The goal of this thera
John Lyder
May 25, 20213 min read


Monoclonal Antibody Contract with Pakistan
We are proud to announce that we through our competence facilitated and supported the Pakistani team, for the signing up CT-P59.
John Lyder
May 17, 20211 min read
bottom of page